Profile_bird

Hey there! CenterWatch is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving CenterWatch's tweets.

Already using Twitter
from your phone? Click here.

CenterWatch

  1. Istodax: recently approved by the #US FDA for cutaneous T-cell #lymphoma. http://ow.ly/HyT6
  2. Arzerra: recently approved by the #US FDA for chronic lymphocytic #leukemia. http://ow.ly/HyRH
  3. Qutenza: recently approved by the US FDA for #neuropathic #pain associated with #postherpetic #neuralgia. http://ow.ly/HyQ6
  4. Stallergenes granted #European approval for Oralair to treat grass pollen #allergy in adults & children. http://ow.ly/HgD1
  5. Multaq approved in the #European #Union for #atrial #fibrillation. http://ow.ly/Hd8F
  6. #pharma i3, Acurian in Patient Recruitment Deal: Pharmaceutical services company i3 has entered into an agreement w... http://bit.ly/5GUaQO
  7. Vivus reported positive results from a phase III trial of avanafil for the treatment of #erectile #dysfunction. http://ow.ly/HcAx
  8. Reach your target audience in the #clinicatrials industry. Advertise with @CenterWatch! http://ow.ly/pE5b
  9. QRxPharma initiated a phase 3 trial in #US of MoxDuo for post-operative #pain following #bunionectomy. http://ow.ly/HgtQ
  10. Kiadis Pharma: phase 2 trial in #Europe & #Canada of ATIR for reduction in transplant related mortality. http://ow.ly/Hg1o
  11. Genta: interim results from ongoing study of a high dose injection of Genasense for Stage IV #melanoma. http://ow.ly/Hcx7
  12. Eurand reported + results from a phase 2/3 trial of Zenpep capsules for chronic #pancreatitis. http://ow.ly/HcpI
  13. Epiphany Bio released + results from a phase 2b trial of valomaciclovir for #Herpes #Zoster (#shingles). http://ow.ly/HciZ
  14. @CenterWatch Honored a Fifth Consecutive Year with an eHealthcare Leadership Award for Best Healthcare Content! http://ow.ly/Bme1
  15. #US FDA approves Cymbalta for the maintenance treatment of generalized #anxiety disorder in adults. http://ow.ly/HbLX
  16. #pharma Progenitor Launches Resourcing Solutions Division, Gains Traction in Vaccines: Emerging markets contract re... http://bit.ly/86XoGY
  17. Bayer Schering initiated an #international phase 3 trial of florbetaben for #Alzheimer's disease. http://ow.ly/H9F3
  18. #US FDA approvs Agriflu, a vaccine by Novartis against #influenza A and B. http://ow.ly/H9Co
  19. Sucampo: + data from multiple studies evaluating lubiprostone for chronic #constipation & #irritable #bowel #syndrome. http://ow.ly/FzQS
  20. 90% of clinical trials miss deadlines-can your company afford the delay? Boost patient recruitment w/ @CenterWatch's CTLS. http://ow.ly/xHVV